Ole Isacson
Corporate Officer/Principal presso Harvard Medical School
Patrimonio netto: 387 $ in data 31/03/2024
Profilo
Ole Isacson is currently the Director of the Neuroregeneration Institute at McLean Hospital, a Professor at Harvard Medical School, and a Member of the Harvard Stem Cell Institute.
He previously served as the Chief Scientific Officer and SVP of Neuroscience R&D at Pfizer Inc. and as the President of the Neural Transplantation and Repair division of the American Society for Neurological Therapeutics.
He was also the President of the International Cell division of the Transplantation Society.
Isacson holds undergraduate and doctorate degrees from the University of Lund.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 15/06/2023 | 121 ( 0.00% ) | 387 $ | 31/03/2024 |
Posizioni attive di Ole Isacson
| Società | Posizione | Inizio |
|---|---|---|
| Harvard Medical School | Corporate Officer/Principal | 01/01/2002 |
McLean Hospital, Inc.
 McLean Hospital, Inc. Hospital/Nursing ManagementHealth Services McLean Hospital, Inc. provides healthcare services. It offers specialized programs for the research and treatment of psychiatric and neurological illnesses, including: depression, bipolar and psychotic disorders, mood and anxiety disorders, substance abuse, geriatric mental illnesses and child adolescent psychiatric disorders. The company was founded in February, 1811 and is headquartered in Belmont, MA. | Corporate Officer/Principal | 01/01/2010 |
Harvard Stem Cell Institute
 Harvard Stem Cell Institute BiotechnologyHealth Technology Harvard Stem Cell Institute provides research regarding stem cells necessary for the understanding of human development and disease and trains next generation stem cell scientists. The company was founded by Doug A. Melton and David T. Scadden in April 2004 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Precedenti posizioni note di Ole Isacson
| Società | Posizione | Fine |
|---|---|---|
| CYCLERION THERAPEUTICS, INC. | Director/Board Member | 19/11/2023 |
| PFIZER, INC. | Chief Tech/Sci/R&D Officer | 01/05/2017 |
| Transplantation Society | Corporate Officer/Principal | - |
| American Society For Neurological Therapeutics | Corporate Officer/Principal | - |
Formazione di Ole Isacson
| University of Lund | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| CYCLERION THERAPEUTICS, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
| Transplantation Society | |
McLean Hospital, Inc.
McLean Hospital, Inc. Hospital/Nursing ManagementHealth Services McLean Hospital, Inc. provides healthcare services. It offers specialized programs for the research and treatment of psychiatric and neurological illnesses, including: depression, bipolar and psychotic disorders, mood and anxiety disorders, substance abuse, geriatric mental illnesses and child adolescent psychiatric disorders. The company was founded in February, 1811 and is headquartered in Belmont, MA. | Health Services |
Harvard Stem Cell Institute
Harvard Stem Cell Institute BiotechnologyHealth Technology Harvard Stem Cell Institute provides research regarding stem cells necessary for the understanding of human development and disease and trains next generation stem cell scientists. The company was founded by Doug A. Melton and David T. Scadden in April 2004 and is headquartered in Cambridge, MA. | Health Technology |
| American Society For Neurological Therapeutics |
- Borsa valori
- Insiders
- Ole Isacson
